Skip to main content

Table 2 Baseline clinical characteristics of TB-HIV co- infected patients in Bahir Dar town, 2012

From: Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study

Base line variable

On ART (n = 272)

Non-ART (n = 150)

X 2Value (df)

P- Value

Past OIs (n = 366)

    

   Yes

105 (43.6%)

55 (44.0%)

0.006

0.937

   No

136 (56.4%)

70 (56.0%)

(1)

 

Past TB Treatment (n = 402)

    

   Yes

58 (22.4%)

31 (21.7%)

0.027

0.869

   No

201 (77.6%)

112 (78.3%)

(1)

 

Functional status (n = 397)

    

   Working

159 (60.9%)

80 (58.8%)

1.363

0.506

   Ambulatory

72 (27.6%)

44 (32.4%)

(2)

 

   Bedridden

30 (11.5%)

12 (8.8%)

  

CD4 count (n = 408)

    

   Mean ± SD

132.9 ± 94.42

312.78 ± 192.8

10.30♦

0.000*

   Median (IQR)

114 (58-185)

291 (183.5-448)

  

Hgb level (mmHg)(n = 357)

    

   Mean ± SD

11.36 ± 2.3

11.46 ± 1.83

0.063♦

0.95

   Median (IQR)

11.3 (10.0-13.0)

12.0 (10.12-13.0)

  

TB diagnosis

    

   Smear Positive PTB

53 (19.5%)

40 (26.7%)

10.434

0.005*

   Smear Negative PTB

107 (39.3%)

36 (24.0%)

(2)

 

   Extra PTB

112 (41.2%)

74 (49.3%)

  

CPT (n = 397)

    

   Prescribed

239 (93.0%)

109 (77.9%)

19.19

0.000*

   Not Prescribed

18 (7.0%)

31 (22.1%)

(1)

 

Outcome of TB Treatment (n = 417)

    

   Cure

37 (13.7%)

16 (11.0%)

8.039

0.045*

   Treatment completed

167 (61.6%)

77 (52.7%)

(3)

 

   Defaulter

18 (6.6%)

9 (6.2%)

  

   Death

49 (18.1%)

44 (30.1%)

  
  1. * Significant at α = 0.05, ♦ = T-test Statistic for independent sample test used.